Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001144204-13-010207

Options or other derivatives

  • Director acquired 119,318 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

STALDER RUEDI · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2013-02-19 Grant or award : show line 1 in the form Common Stock Options +119,318 $0.13 2023-02-19 119,318 1,918,339 D
Loading xslF345X03/form457960_20130220030315-.xml…